Johnson & Johnson announces its entry into the US robotic surgery market, says it is ready to enter hospital rooms that could not previously accommodate 'robots'

Johnson & Johnson (J&J) has received marketing authorization from the US Food and Drug Administration (FDA) for its Ottava robotic surgical system, clearing the healthcare major to enter the fast-growing soft-tissue robotic surgery market. The approval is an important milestone for J&J’s medical technology business as it seeks to challenge Intuitive Surgical, whose da Vinci system dominates robotic-assisted surgery.

Raccontata dabenzinga.comtimesofindia.indiatimes.comsiliconrepublic.com